EligibleTrials

Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction

Recruiting · NCT07614256 · Observational (researchers observe without assigning treatment) · Lead sponsor: Guangxi Medical University

View the official record on ClinicalTrials.gov →
Prostate cancer

Interventions studied

No Intervention: Observational Cohort

What this trial is about

This is a multicenter observational study. A deep learning model integrated with multimodal imaging and digital pathology spatial registration is built based on preoperative multiparametric magnetic resonance imaging, transrectal ultrasound and postoperative digital pathological whole slide images. The study is designed to achieve accurate prediction of clinically significant prostate cancer and non-invasive risk stratification. Unnecessary prostate biopsy and overdiagnosis can be reduced to support the optimization of clinical diagnosis and treatment strategies.

Who can take part

Age range
40 Years to 90 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.